<p>Esperion Therapeutics, Inc. (ESPR) 周一宣布已与 Micro Labs USA, Inc. 及其附属公司 Micro Labs Ltd. 达成和解协议，以解决专利诉讼。根据协议，Micro Labs 同意不在</p>
<p>2040 年 4 月 19 日之前在美国市场销售 Nexletol 的仿制药版本。</p>
<p>Esperion 是一家商业阶段的生物制药公司，之前已对 Micro Labs 提起专利侵权诉讼。该诉讼是针对 Micro Labs 提交的简化新药申请，寻求在相关专利到期之前获得销售 Nexletol 仿制药的批准。</p>
<p>Esperion 还对其他被告 Accord Healthcare Inc; Alkem Laboratories Ltd.; Aurobindo Pharma Limited; Dr. Reddys Laboratories Inc.; Hetero USA Inc.; MSN Pharmaceuticals Inc.; Renata Ltd. 和 Sandoz Inc. 提起了持续的专利诉讼。</p>
<p>如需评论和反馈，请联系：editorial@rttnews.com</p>
<p>商业新闻</p>

ESPR

<p>Esperion Therapeutics, Inc.（ESPR）已与 Micro Labs USA, Inc.和 Micro Labs Ltd.达成专利诉讼和解，阻止在美国市场上销售 Nexletol 的仿制药，直至 2040 年 4 月 19 日。此次和解是在 Esperion 对 Micro Labs 提起诉讼后达成的，原因是其在专利到期前提交了仿制药的简化新药申请。Esperion 仍在对包括 Accord Healthcare 和 Dr. Reddy's Laboratories 在内的其他被告进行诉讼</p>

<p>Esperion Therapeutics, Inc. (ESPR) Monday announced that it has entered into a settlement agreement with Micro Labs USA, Inc. and its affiliate Micro Labs Ltd. to resolve a patent litigation. As per the agreement, Micro Labs has agreed not to</p>
<div class="lb-trans"><p>Esperion Therapeutics, Inc. (ESPR) 周一宣布已与 Micro Labs USA, Inc. 及其附属公司 Micro Labs Ltd. 达成和解协议，以解决专利诉讼。根据协议，Micro Labs 同意不在</p>
</div><p>market a generic version of Nexletol in the United States prior to April 19, 2040.</p>
<div class="lb-trans"><p>2040 年 4 月 19 日之前在美国市场销售 Nexletol 的仿制药版本。</p>
</div><p>Esperion, a commercial stage biopharmaceutical company, has earlier filed a patent infringement lawsuit against the Micro Labs. The litigation was in response to Micro Labs' filing of Abbreviated New Drug Application seeking approval to market a generic version of Nexletol, prior to the expiration of the applicable patents.</p>
<div class="lb-trans"><p>Esperion 是一家商业阶段的生物制药公司，之前已对 Micro Labs 提起专利侵权诉讼。该诉讼是针对 Micro Labs 提交的简化新药申请，寻求在相关专利到期之前获得销售 Nexletol 仿制药的批准。</p>
</div><p>Esperiod has ongoing patent litigation against the remaining defendants Accord Healthcare Inc; Alkem Laboratories Ltd.; Aurobindo Pharma Limited, Dr. Reddys Laboratories Inc., Hetero USA Inc., MSN Pharmaceuticals Inc., Renata Ltd. and Sandoz Inc.</p>
<div class="lb-trans"><p>Esperion 还对其他被告 Accord Healthcare Inc; Alkem Laboratories Ltd.; Aurobindo Pharma Limited; Dr. Reddys Laboratories Inc.; Hetero USA Inc.; MSN Pharmaceuticals Inc.; Renata Ltd. 和 Sandoz Inc. 提起了持续的专利诉讼。</p>
</div><p>For comments and feedback contact: editorial@rttnews.com</p>
<div class="lb-trans"><p>如需评论和反馈，请联系：editorial@rttnews.com</p>
</div><p>Business News</p>
<div class="lb-trans"><p>商业新闻</p>
</div>

Esperion 与 Micro Labs 就仿制药 Nexletol 的专利诉讼达成和解